CANCER CENTRE LONDON LLP
Get an alert when CANCER CENTRE LONDON LLP files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2025-09-30
Overdue
Confirmation statement due
2027-04-17 (in 11mo)
Last made up 2026-04-03
Watchouts
Cash
£1K
0% vs 2022
Net assets
£2M
+147.3% vs 2022
Employees
59
-3.3% vs 2022
Profit before tax
£1M
-7% vs 2022
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2025-09-30.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Name history
Renamed 2 times since incorporation
- CANCER CENTRE LONDON LLP 2010-11-30 → present
- CANCER CENTRE LLP 2010-11-25 → 2010-11-30
- PARKSIDE ONCOLOGY CLINIC LLP 2010-02-11 → 2010-11-25
Net assets
2-year trend · vs Unclassified median
Accounts
2-year trend · latest reflected 2023-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Turnover | £15,534,000 | £16,979,000 | |
| Operating profit | £1,552,000 | £1,440,000 | |
| Profit before tax | £1,548,000 | £1,440,000 | |
| Net profit | £616,000 | £542,000 | |
| Cash | £1,000 | £1,000 | |
| Total assets less current liabilities | £946,000 | £2,339,000 | |
| Net assets | £946,000 | £2,339,000 | |
| Equity | £946,000 | £2,339,000 | |
| Average employees | 61 | 59 | |
| Wages | £1,885,000 | £1,960,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating margin | 10.0% | 8.5% | |
| Net margin | 4.0% | 3.2% | |
| Return on capital employed | 164.1% | 61.6% | |
| Gearing (liabilities / total assets) | 74.8% | 53.0% | |
| Current ratio | 1.09x | 1.56x | |
| Interest cover | 388.00x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The members have assessed the partnerships' ability to continue as a going concern. This assessment has included a review of the company's recent trading performance and continued net asset position, as well as any potential future impact of external factors on the business. Based on this assessment and at the time of approving the financial statements, the members have a reasonable expectation that the Limited Liability Partnership has adequate resources to continue in operational existence for the period ending 12 months from the date of their approval of these financial statements. Thus, the members continue to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “In December 2023, Aspen Healthcare Limited, the parent company, granted a call option to ICON to purchase all of the interests in the Limited Liability Partnership. The option can be exercised at any time within the next three years to 31 December 2026. Simultaneously, the Limited Liability Partnership agreed to receive a £2.1 million interest-free loan from ICON. The loan was received on 10 January 2024 and subsequent drawdowns will be non-basic and should be accounted for at fair value through statement of comprehensive income. The loan contains conditions relating to the call option issued by AHL at the date of signing these accounts, the option has not been exercised.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ICON HOLDINGS SERVICES UK LIMITED | Corporate Llp Designated Member | 2024-12-05 | — | — |
| INTEGRATED CLINICAL ONCOLOGY NETWORK UK LTD | Corporate Llp Designated Member | 2023-12-19 | — | — |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| POWLES, Trevor James, Professor | Llp Designated Member | 2010-03-01 | 2013-04-02 |
| RAYNER, Charlotte Frances Jessica, Dr | Llp Designated Member | 2010-03-01 | 2022-09-30 |
| ASPEN HEALTHCARE LIMITED | Corporate Llp Designated Member | 2015-02-05 | 2024-12-05 |
| ASPEN HEALTHCARE LIMITED | Corporate Llp Designated Member | 2010-02-11 | 2015-02-05 |
| GLOBAL HEALTHCARE PARTNERS LIMITED | Corporate Llp Designated Member | 2010-02-11 | 2010-03-01 |
| MSCP WELLBEING LIMITED | Corporate Llp Designated Member | 2022-09-30 | 2023-12-19 |
| TREVOR POWLES ONCOLOGY LIMITED | Corporate Llp Designated Member | 2013-04-01 | 2021-12-31 |
| KELLEHER, Muireann Treasa, Dr | Llp Member | 2014-07-01 | 2022-09-30 |
| KIRBY, Anna Melinda, Dr | Llp Member | 2013-04-01 | 2022-09-30 |
| LOWDELL, Charles, Dr | Llp Member | 2010-08-17 | 2022-09-30 |
| PHILLIPS, Robert Hugh, Dr | Llp Member | 2010-03-01 | 2018-05-10 |
| POWLES, Raymond Leonard, Professor | Llp Member | 2010-03-01 | 2013-04-02 |
| DR R A HUDDART LIMITED | Corporate Llp Member | 2014-07-01 | 2022-09-30 |
| IAN E. SMITH LIMITED | Corporate Llp Member | 2014-07-01 | 2022-09-30 |
| LONDON HAEMATO-ONCOLOGY LIMITED | Corporate Llp Member | 2013-04-01 | 2022-09-30 |
| ONCOLOGY ASSOCIATES UK LTD | Corporate Llp Member | 2013-04-01 | 2022-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Integrated Clinical Oncology Network Uk Ltd | Corporate entity | voting-rights-75-to-100-percent-limited-liability-partnership, right-to-share-surplus-assets-75-to-100-percent-limited-liability-partnership, right-to-appoint-and-remove-members-limited-liability-partnership | 2024-12-05 | Active |
| Aspen Healthcare Limited | Corporate entity | voting-rights-75-to-100-percent-limited-liability-partnership, right-to-share-surplus-assets-75-to-100-percent-limited-liability-partnership, right-to-appoint-and-remove-members-limited-liability-partnership | 2016-04-06 | Ceased 2024-12-05 |
Filing timeline
Last 20 of 103 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-10 | LLCS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-29 | GUARANTEE2 | other | Legacy | |
| 2026-01-29 | AGREEMENT2 | other | Legacy | |
| 2025-04-22 | LLCH02 | officers | Change corporate member limited liability partnership with name change date | |
| 2025-04-11 | LLAD04 | address | Move registers to registered office limited liability partnership with new address | |
| 2025-04-11 | LLAD02 | address | Change sail address limited liability partnership with old address new address | |
| 2025-04-10 | LLCS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-10 | LLPSC05 | persons-with-significant-control | Change to a person with significant control limited liability partnership | |
| 2025-04-10 | LLCH02 | officers | Change corporate member limited liability partnership with name change date | |
| 2025-04-03 | ANNOTATION | miscellaneous | Legacy | |
| 2025-04-02 | LLCH02 | officers | Change corporate member limited liability partnership with name change date | |
| 2025-04-02 | LLAD01 | address | Change registered office address limited liability partnership with date old address new address | |
| 2024-12-16 | LLPSC02 | persons-with-significant-control | Notification of a person with significant control limited liability partnership | |
| 2024-12-16 | ANNOTATION | miscellaneous | Legacy | |
| 2024-12-09 | LLPSC07 | persons-with-significant-control | Cessation of a person with significant control limited liability partnership | |
| 2024-12-09 | LLAD01 | address | Change registered office address limited liability partnership with date old address new address | |
| 2024-12-09 | LLTM01 | officers | Termination member limited liability partnership with name termination date | |
| 2024-12-09 | LLAP02 | officers | Appoint corporate member limited liability partnership with appointment date | |
| 2024-11-04 | AA | accounts | Accounts with accounts type full | |
| 2024-04-10 | LLCS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31
-
Turnover
+9.3%
£15,534,000 £16,979,000
-
Cash
0%
£1,000 £1,000
-
Net assets
+147.3%
£946,000 £2,339,000
-
Employees
-3.3%
61 59
-
Operating profit
-7.2%
£1,552,000 £1,440,000
-
Profit before tax
-7%
£1,548,000 £1,440,000
-
Wages
+4%
£1,885,000 £1,960,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers